ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1), based on phase 1 ...
Modern Engineering Marvels on MSN
MD-11 engine-mount fatigue puts aging cargo fleets under a microscope
The most consequential mechanical failures in transport aviation are often the ones which start as hairline cracks hidden ...
Lucid Group, Inc. , maker of the world's most advanced electric vehicles, today announced that the Lucid Gravity SUV has been recognized by the MotorTrend Best Tech Awards for delivering the Best ...
Justin Jaffe is the Managing Editor for CNET Money. He has more than 20 years of experience publishing books, articles and research on finance and technology for Wired, IDC and others. He is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback